Abstraction Health
Andrew Huberman

Does Andrew Huberman recommend Rhodiola Rosea?

Andrew Huberman recommends Rhodiola Rosea in some contexts, but has also raised cautions.

Published research rates it weak evidence. Of Andrew Huberman's 60 tracked claims, 22 are supported or partially supported by studies on PubMed.

🟠Weak Evidence

Evidence last reviewed May 2026

60
Tracked claims
22
Supported / partial
20
Research studies

Andrew Huberman on Rhodiola Rosea β€” 60 claims

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use to prevent sleep impairment
Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies provide key findings, populations, or limitations data that can be directly evaluated, making it impossible to confirm or refute Huberman's claim about Rhodiola's stim…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical recommended dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ 200 to 400 mg of standardized extract per day
Insufficient evidence to assessHigh confidence

None of the 20 publications listed provide explicit dosing recommendations for Rhodiola rosea in the 200–400 mg/day range. While several RCTs and systematic reviews (e.g., PMID 37495266, PMID 39601362…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ typical daily dose
Insufficient evidence to assessHigh confidence

While the published research list includes potentially relevant studies (a systematic review of Rhodiola RCTs, WFSBP/CANMAT clinical guidelines, and several RCTs), none of the provided records include…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use to prevent sleep impairment
Insufficient evidence to assessHigh confidence

None of the 10 provided studies contain extractable key findings (all show 'None' for key findings, populations, and limitations), making it impossible to directly evaluate Huberman's claim about Rhod…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ typical daily dose
Insufficient evidence to assessHigh confidence

While the provided literature includes relevant studies on Rhodiola rosea (including a strong-quality systematic review, PMID 37495266, and WFSBP/CANMAT clinical guidelines, PMID 35311615), none of th…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use to prevent sleep impairment
Insufficient evidence to assessHigh confidence

None of the 10 published studies provided contain key findings or data that directly address Rhodiola's stimulating properties or its effects on sleep timing. While the study list includes relevant st…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use to prevent sleep impairment
Insufficient evidence to assessHigh confidence

None of the 20 listed studies directly examine the timing of Rhodiola rosea supplementation in relation to sleep outcomes or test whether evening use impairs sleep quality. The narrative review on die…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use to prevent sleep impairment
Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies provide key findings, populations, or limitations data, making it impossible to directly evaluate Huberman's claim that Rhodiola has a stimulating effect that can impa…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ typical daily dose
Partially supportedHigh confidence

The provided literature does not directly state that 200–400 mg/day is the standard dose for Rhodiola rosea supplementation. However, the systematic review (PMID: 37495266) on Rhodiola supplementation…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œRhodiola appears to have a stimulating effect and is generally better taken in the morning or early afternoon rather than in the evening, as it can impair sleep if taken too late.”

Extracted claim

Rhodiola has a stimulating effect and should be taken in the morning or early afternoon, not in the evening, as it can impair sleep if taken too late.

⏱ morning or early afternoonπŸ“ avoid evening use due to stimulating effect that can impair sleep
Insufficient evidence to assessHigh confidence

None of the 20 listed studies directly examine the timing of Rhodiola rosea supplementation relative to sleep quality or provide evidence that evening dosing impairs sleep. The available research (inc…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ typical daily dose
Insufficient evidence to assessHigh confidence

While the provided research list includes potentially relevant studies (e.g., PMID 37495266, a strong-quality systematic review on Rhodiola rosea and sports performance, and PMID 35311615, strong-qual…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Direct recommendation

β€œThe typical dose is 200 to 400 milligrams of a standardized extract per day.”

Extracted claim

The typical dose of Rhodiola is 200 to 400 milligrams of a standardized extract per day.

200–400 milligramsstandardized extract⏱ dailyπŸ“ typical daily dose
Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies provide extractable key findings, populations, or dosing details that directly confirm or refute the claimed 200–400 mg/day range for standardized Rhodiola rosea extra…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œMultiple trials have shown that Rhodiola reduces mental fatigue in physicians on night shifts, students during exam periods, and military cadets under sleep deprivation. The effect size is moderate but reproducible β€” typically around a 20 to 30 percent improvement in cognitive performance metrics.”

Extracted claim

Multiple trials have shown that Rhodiola reduces mental fatigue in physicians on night shifts, students during exam periods, and military cadets under sleep deprivation, with approximately 20–30% improvement in cognitive performance metrics.

Partially supportedHigh confidence

The research base includes a systematic review (PMID 37495266, rated strong quality) on Rhodiola rosea and physical/cognitive performance, a strong-quality meta-analysis on nutraceuticals for psychiat…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œOne well-designed study compared Rhodiola to sertraline β€” an SSRI β€” for mild to moderate depression and found comparable effects on depressive symptoms with fewer side effects.”

Extracted claim

A well-designed study compared Rhodiola to sertraline for mild to moderate depression and found comparable effects on depressive symptoms with fewer side effects.

Insufficient evidence to assessHigh confidence

None of the 10 provided studies directly examine Rhodiola rosea compared to sertraline for mild to moderate depression. The retrieved literature focuses predominantly on athletic performance, exercise…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œthe adaptogen category has a lot of marketing hype around it, but Rhodiola is one of the better-studied members of this category and I think the evidence is worth taking seriously.”

Extracted claim

The adaptogen category has a lot of marketing hype, but Rhodiola is one of the better-studied members and the evidence is worth taking seriously.

Partially supportedHigh confidence

The claim that Rhodiola is 'better-studied' among adaptogens and worth taking seriously is partially supported by the breadth of study designs present in the retrieved literature, which includes multi…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œMultiple trials have shown that Rhodiola reduces mental fatigue in physicians on night shifts, students during exam periods, and military cadets under sleep deprivation. The effect size is moderate but reproducible β€” typically around a 20 to 30 percent improvement in cognitive performance metrics.”

Extracted claim

Multiple trials have shown that Rhodiola reduces mental fatigue in physicians on night shifts, students during exam periods, and military cadets under sleep deprivation, with a typical improvement of 20 to 30 percent in cognitive performance metrics.

Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies directly address the specific populations cited in Huberman's claim (physicians on night shifts, students during exam periods, or military cadets under sleep deprivati…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œthe adaptogen category has a lot of marketing hype around it, but Rhodiola is one of the better-studied members of this category and I think the evidence is worth taking seriously.”

Extracted claim

The adaptogen category has a lot of marketing hype, but Rhodiola is one of the better-studied members and the evidence is worth taking seriously.

Partially supportedHigh confidence

The expert's claim that Rhodiola is 'better-studied' among adaptogens and that its evidence is 'worth taking seriously' is partially supported by the research corpus. The presence of a strong-quality…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œOne well-designed study compared Rhodiola to sertraline β€” an SSRI β€” for mild to moderate depression and found comparable effects on depressive symptoms with fewer side effects.”

Extracted claim

A well-designed study compared Rhodiola to sertraline for mild to moderate depression and found comparable effects on depressive symptoms with fewer side effects.

Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies directly address a comparison between Rhodiola rosea and sertraline for mild to moderate depression. The retrieved literature focuses primarily on sports performance,…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œthe adaptogen category has a lot of marketing hype around it, but Rhodiola is one of the better-studied members of this category and I think the evidence is worth taking seriously.”

Extracted claim

The adaptogen category has a lot of marketing hype, but Rhodiola is one of the better-studied members and the evidence is worth taking seriously.

Partially supportedHigh confidence

The claim that Rhodiola is 'better-studied' among adaptogens and that its evidence is 'worth taking seriously' receives partial support from the literature provided. The presence of a strong-quality s…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Evidence-backed claim

β€œthe adaptogen category has a lot of marketing hype around it, but Rhodiola is one of the better-studied members of this category and I think the evidence is worth taking seriously.”

Extracted claim

The adaptogen category has a lot of marketing hype, but Rhodiola is one of the better-studied members and the evidence is worth taking seriously.

Partially supportedHigh confidence

The claim that Rhodiola is among the better-studied adaptogens with evidence worth taking seriously receives partial support from the available literature. The presence of a strong-quality systematic…

Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only β€” consult a healthcare provider before starting any supplement.

Back to Andrew Huberman